ZTS · Zoetis Inc. · Executive Compensation

$83.82 +0.86 (+1.04%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$34.06B

406.32M

Volume · Nov 13 3.15M Avg daily vol (3M) 4.53M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Juan Ramón Alaix	Chief Executive Officer	$1,200,000	—	$15,322,769	$2,399,982	$1,872,000	$350,668	$21,145,419
Glenn C. David	Executive Vice President and Chief Financial Officer	$690,000	—	$1,612,477	$537,487	$695,520	$136,866	$3,672,350
Clinton A. Lewis	Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human	$690,000	—	$1,349,964	$449,997	$654,120	$412,272	$3,556,353
Kristin C. Peck	Executive Vice President and Group President, U.S. Operations, Business Development and Strategy	$690,000	—	$1,349,964	$449,997	$695,520	$144,683	$3,330,164
Catherine A. Knupp	Executive Vice President and President of Research and Development	$690,000	—	$1,349,964	$449,997	$678,960	$142,301	$3,311,222

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Juan Ramón Alaix	Chief Executive Officer	$1,200,000	—	$5,399,942	$2,699,990	$2,047,500	$321,968	$11,669,400
Clinton A. Lewis	Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human	$675,000	—	$999,930	$499,986	$729,000	$1,721,890	$4,625,806
Kristin C. Peck	Executive Vice President and Group President, U.S. Operations, Business Development and Strategy	$675,000	—	$999,930	$499,986	$734,400	$129,608	$3,038,924
Glenn C. David	Executive Vice President and Chief Financial Officer	$626,250	—	$1,066,567	$533,323	$691,380	$117,651	$3,035,171
Catherine A. Knupp	Executive Vice President and President of Research and Development	$626,250	—	$999,930	$499,986	$676,350	$121,425	$2,923,941

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Juan Ramón Alaix	Chief Executive Officer	$1,190,000	—	$4,866,579	$2,433,331	$1,750,000	$288,859	$10,528,769
Clinton A. Lewis	Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human	$655,000	$300,000	$933,252	$466,666	$607,060	$1,485,268	$4,447,246
Kristin C. Peck	Executive Vice President and Group President, U.S. Operations, Business Development and Strategy	$655,000	$300,000	$933,252	$466,666	$599,440	$112,245	$3,066,603
Catherine A. Knupp	Executive Vice President and President of Research and Development	$582,500	$300,000	$933,252	$466,666	$534,245	$99,895	$2,916,558
Glenn C. David	Executive Vice President and Chief Financial Officer	$596,250	$150,000	$933,252	$466,666	$550,041	$101,388	$2,797,597

Executive changes

Person	Role	Change	Effective	Filed
Iris Knobloch	Board of Directors	Appointed	2026-12-01	2026-10-13
James (Jay) Saccaro	Executive Vice President, Chief Financial Officer and Chief Operating Officer	Appointed	2026-08-17	2026-08-06
James Saccaro	Executive Vice President, Chief Financial Officer and Chief Operating Officer	Appointed	2026-08-17	2026-08-06
James Saccaro	Executive Vice President, Chief Financial Officer and Chief Operating Officer	Appointed	2026-08-17	2026-08-06
Stephanie Tilenius	director	Appointed	2026-05-20	2026-05-22
Mark Stetter	director	Appointed	2026-05-20	2026-05-22
Kristin C. Peck	director	Appointed	2026-05-20	2026-05-22
Willie M. Reed	director	Appointed	2026-05-20	2026-05-22
Gregory Norden	director	Appointed	2026-05-20	2026-05-22
Antoinette R. Leatherberry	director	Already on the board Since at least 2020: re-election or new board role	2026-05-20	2026-05-22
Michael B. McCallister	director	Appointed	2026-05-20	2026-05-22
Frank A. D'Amelio	director	Appointed	2026-05-20	2026-05-22
Sanjay Khosla	director	Appointed	2026-05-20	2026-05-22
Gavin D.K. Hattersley	director	Already on the board Since at least 2024: re-election or new board role	2026-05-20	2026-05-22
Vanessa Broadhurst	director	Already on the board Since at least 2022: re-election or new board role	2026-05-20	2026-05-22
Paul M. Bisaro	director	Appointed	2026-05-20	2026-05-22
Louise M. Parent	Board of Directors	Retired	2026-05-20	2026-05-22
Stephanie Tilenius	Board of Directors	Appointed	2025-12-01	2025-10-28
Mark Stetter	Board of Directors of the company	Appointed	2025-05-21	2025-05-22
Robert Scully	Board of Directors of Zoetis Inc.	Retired	2025-05-21	2025-05-22
Dr. Linda Rhodes	Board of Directors	Retired	2024-05-21	2024-05-23
Roxanne Lagano	interim General Counsel and Corporate Secretary	Appointed	—	2024-04-16
Gavin D.K. Hattersley	Board of Directors	Appointed	2024-04-01	2024-04-01
Glenn David	Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices	Terminated	2023-02-05	2023-02-07
Jamie Brannan	Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ)	Appointed	2022-11-01	2022-10-25

Leadership

Juan Ramón Alaix CEO
James (Jay) Saccaro CFO
James Saccaro CFO, COO
Roxanne Lagano General Counsel
Antoinette R. Leatherberry Board Member
Frank A. D'Amelio Board Member
Gavin D.K. Hattersley Board Member
Gregory Norden Board Member
Iris Knobloch Board Member
Kristin C. Peck Board Member
Mark Stetter Board Member
Michael B. McCallister Board Member
Paul M. Bisaro Board Member
Sanjay Khosla Board Member
Stephanie Tilenius Board Member
Vanessa Broadhurst Board Member
Willie M. Reed Board Member

Key facts CIK 1555280 CUSIP 98978V103 13F (30d) 1132 filings 1027 filers Visit website Investor relations